Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Eimeira Padilla-Tolentino"'
Publikováno v:
INNOVATIONS in Pharmacy, Vol 12, Iss 1 (2021)
Background and Introduction: Obtaining patient medication histories during emergency department (ED) admissions is an important step towards identifying potential errors that could otherwise remain in the patient’s active medication list. This is a
Externí odkaz:
https://doaj.org/article/57004f4bc9f34fca85d78ad74902b9fb
Autor:
Michael J, McAlister, Dusten T, Rose, F Parker, Hudson, Eimeira, Padilla-Tolentino, Theresa C, Jaso
Publikováno v:
American Journal of Health-System Pharmacy. 80:S33-S41
Purpose To compare rates of treatment failure for patients with bloodstream infections (BSIs) due to Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis who received oral step-down antibiotic therapy with either a fluoroquinolone (FQ) or tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d85f6d3e0e99ccc6bd7c784c68b19864
https://doi.org/10.1093/ajhp/zxac202
https://doi.org/10.1093/ajhp/zxac202
Publikováno v:
Journal of Oncology Pharmacy Practice. 26:882-890
Objective To decrease the number of orders and total hospital spend for inpatient use of antineoplastic drugs of interest, while evaluating each case for urgent or emergent need for administration. Methodology This study is a multicenter, retrospecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02ddfaa2b46517c538037c5000a95de6
https://doi.org/10.1177/1078155219877920
https://doi.org/10.1177/1078155219877920
Publikováno v:
Pharmacotherapy
Study objectives Current neurocritical care guidelines recommend 50 IU/kg four-factor prothrombin complex concentrate (4PCC) for factor Xa inhibitor (FXaI) reversal in intracranial hemorrhage (ICH) based on few clinical studies conducted among non-IC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dbfa0bbe192b8718c0cd48440ed7ab6
https://pubmed.ncbi.nlm.nih.gov/33866591
https://pubmed.ncbi.nlm.nih.gov/33866591
Publikováno v:
INNOVATIONS in Pharmacy, Vol 12, Iss 1 (2021)
Innovations in Pharmacy
Innovations in Pharmacy
Background and Introduction: Obtaining patient medication histories during emergency department (ED) admissions is an important step towards identifying potential errors that could otherwise remain in the patient’s active medication list. This is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23b058a68c1471dbb9b7653d290903d5
https://pubs.lib.umn.edu/index.php/innovations/article/view/3377
https://pubs.lib.umn.edu/index.php/innovations/article/view/3377
Autor:
Jason Shumake, Eimeira Padilla-Tolentino, Athena L V Hobbs, Katherine M. Shea, Kristin Mondy, Derek J. Templet
Publikováno v:
American Journal of Health-System Pharmacy. 75:876-885
Purpose The impact of an antiretroviral stewardship strategy on medication error rates was evaluated. Methods This single-center, retrospective, comparative cohort study included patients at least 18 years of age infected with human immunodeficiency
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbc1cd4e290953c70f840d839c74fc1b
https://doi.org/10.2146/ajhp170420
https://doi.org/10.2146/ajhp170420
Publikováno v:
The Journal of Pediatric Pharmacology and Therapeutics. 22:15-21
OBJECTIVES Children have decreased levels of antithrombin III (AT III) compared to adults. These levels may be further decreased during acute illness. Administration of exogenous AT III can increase anticoagulant efficacy. The objective of this study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6765ccbdde93181e8ebc44cd809c128
https://doi.org/10.5863/1551-6776-22.1.15
https://doi.org/10.5863/1551-6776-22.1.15
Autor:
Eimeira Padilla-Tolentino, Patricia Cervenka, Ronda Machen, Kristin Bohannon, Carolyn E Ragsdale
Publikováno v:
Clinical pediatrics. 58(5)
A retrospective chart review was done to evaluate the efficacy of a course of dexamethasone for pediatric patients hospitalized with a mild to moderate acute asthma exacerbation compared with a prednisone-based regimen. Patients were identified based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2ba956f9b52ab71fd1f11633fa3dfab
https://pubmed.ncbi.nlm.nih.gov/30854887
https://pubmed.ncbi.nlm.nih.gov/30854887
Autor:
Evan J. Peterson, Kirsten M. Roberts, Tamara B. Knight, Eimeira Padilla-Tolentino, Manasa S. Murthy
Publikováno v:
Thrombosis
Background. Trials have shown that novel oral anticoagulants may decrease length of stay versus warfarin. A comparison of length of stay in the treatment of pulmonary embolism (PE) has not been performed outside post hoc analysis of a large clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::956c39dc5f1a73163775fd057bda3805